Keratin 14 Polyclonal Antibody, Purified

Pricing & Availability
Clone
Poly19053 (See other available formats)
Isotype
Rabbit Polyclonal
KifLiakath
Whole mount mouse tail epidermis was stained with purified anti-Keratin 14 (green, clone Poly19053), purified anti-Keratin 15 (orange, clone Poly18339) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Kif Liakath.
  • KifLiakath
    Whole mount mouse tail epidermis was stained with purified anti-Keratin 14 (green, clone Poly19053), purified anti-Keratin 15 (orange, clone Poly18339) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Kif Liakath.
  • Poly19053_Purified_Keratin_14_Antibody_IHC_030615
    Strong cytoplasmic staining of the epidermis in normal human skin tissue detected with anti-K14 (clone Poly19053).
Cat # Size Price Quantity Avail. Save
905301 100 µL $374
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Instructions for Use (pdf)

Product Details

Product Information

Intended Use:

In Vitro Diagnostic (IVD). Use in immunohistochemistry (IHC) test methods only.

The polyclonal antibody Poly19053 is used for the in vitro examination of human biological samples using immunohistochemistry (IHC) methods for the qualitative identification of Keratin 14. The clinical interpretation of any staining or its absence should be complemented by morphological studies and proper controls and should be evaluated within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist.

Reactivity
Human, Mouse, Rat, Dog, Primate
Formulation
Phosphate-buffered solution + 0.03% Thimerosal.
Preparation
The antibody was purified by peptide affinity chromatography.
Concentration
1.0 mg/ml
Storage & Handling
When stored at ≤ -20°C, product is stable until the date shown on the label. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody. If thawed and stored between 2°C and 8°C, product is stable for 24 months from the date of thaw or until the expiry date on the label, whichever comes first.
Recommended Usage

Each lot of this antibody is quality control tested by immunohistochemical staining.

The optimal working dilution should be determined for each specific assay condition.
IHC: 1:1,000 with either biotin based detection systems such as USA Ultra Streptavidin Detection (Cat. No. 929501).

Tissue Sections: Paraffin-embedded tissues, frozen tissues
Pretreatment: For optimal staining, the sections should be pretreated with an antigen unmasking solution such as Citrate Buffer Retrieval solution (Cat. No. 928502, 928602).
Incubation: 60 minutes at room temperature

Precautions for Use: Use appropriate personal protective equipment and safety practices per universal precautions when working with this reagent. Refer to the reagent safety data sheet.

Application References

(PubMed link indicates BioLegend citation)
  1. Wend P, et al. Wnt/?-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours. EMBO J., Jun 2013.
  2. Welm AL, Kim S, Welm BE, Bishop JM. MET and MYC cooperate in mammary tumorigenesis. Proc Natl Acad Sci USA 102(12):4324-9, 2005. [IHC] PubMed
  3. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 410:710-714, 2001.
  4. Yuspa SH, Kilkenny AD, Steinert PM, Roop DR. Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in-vitro. J Cell Biol 109:1207-1217, 1989.
  5. Roop DR, Cheng CK, Titterington L, Meyers CA, Stanley JR, Steinert PM, Yuspa SH. Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem 259:8037-8040, 1984.
  6. Liang Y. 2011. Patholog Res Int. 2011:93674. (IHC) PubMed
  7. Easter SL, et al. 2014. PLoS One. 9:113247. (IF, WB) PubMed
  8. Frew IJ, et al. 2008. Mol Cell Biol.28:4536. (IHC) PubMed
  9. Levy V, et al. 2007. FASEB J. 21:1358. (IHC) PubMed
  10. Sengupta A, et al. 2010. PLoS One. 5:12249. (IHC) PubMed
  11. Smith BA, et al. 2012. Genes Cancer.3:550. (IHC) PubMed
Product Citations
  1. Böttcher J, et al. 2015. J Immunol. 195: 5066 - 5076. PubMed
  2. Welm A, et al. 2005. Proc Natl Acad Sci U S A. 102:4324-4329. PubMed
  3. Liang Y 2011. Patholog Res Int. 2011:936794. PubMed
  4. Frew I, et al. 2008. Mol Cell Biol. 28:4536-4548. PubMed
  5. Levy V, et al. 2007. FASEB J. 21:1358-1366. PubMed
  6. Sengupta A, et al. 2010. PLoS One. 5:e12249. PubMed
  7. Smith B, et al. 2012. Genes Cancer. 3:550-563. PubMed
  8. Easter S, et al. 2014. PLoS One. 9:e113247. PubMed
  9. Cheung K, et al. 2016. Proc Natl Acad Sci U S A. 113: 854 - 863. PubMed
  10. Lichtenberger B, Watt M 2016. Nat Commun. 7:10537. PubMed
  11. Nair S, et al. 2016. Nat Commun. 7:10913. PubMed
  12. Alrefai H, et al. 2016. Nat Commun. 7:11724. PubMed
  13. Dahlhoff M, et al. 2016. Development. 143: 1823 - 1831. PubMed
  14. Kriegbaum M, et al. 2016. Sci Rep. 6: 25833. PubMed
  15. Turpin J, et al. 2016. Oncogene. 10.1038/onc.2016.129. PubMed
  16. Panousopoulou E, et al. 2016. J Cell Sci. 129: 1915 - 1927. PubMed
  17. Sada A, et al. 2016. Nat Cell Biol. 18: 619-631. PubMed
  18. Annunziato S, et al. 2016. Genes Dev. 30: 1470 - 1480. PubMed
  19. Wuidart A, et al. 2016. Genes Dev. 30: 1261 - 1277. PubMed
  20. Nahidiazar L, et al. 2016. PLoS One. 11: 0158884. PubMed
  21. E Joo, I Lombaert, K Yamada 2016. J Dent Res. 95(13):1518-1527. PubMed
  22. Hasche D, et al. 2016. PLoS One. 11: 0161283. PubMed
  23. Yoo K, et al. 2016. Mol Cell Biol. 36: 2108 - 2120. PubMed
  24. Goguet-Rubio P, et al. 2016. Proc Natl Acad Sci U S A. 113: 11004 - 11009. PubMed
  25. Shatirishvili M, et al. 2016. Cell Death Dis. 7:e2461. PubMed
  26. Feinberg T, et al. 2016. Development. 143: 3956 - 3968. PubMed
  27. Goreczny G, et al. 2016. Oncogene. 10.1038/onc.2016.422. PubMed
  28. Scheele C, et al. 2017. Nature. 542:313-317. PubMed
  29. Guorui H, et al. 2017. Nat Commun. 8:14351. PubMed
  30. Tao L, et al. 2017. Nat Commun. 8:14431. PubMed
  31. Larribere L,et al. 2017. Stem Cell Reports.. 10.1016/j.stemcr.2017.08.023. PubMed
  32. Wang J, et al. 2017. Cancer Prev Res (Phila). 10:684. PubMed
  33. Reeves MQ, et al. 2018. Nat Cell Biol. 20:699. PubMed
  34. Roux LN, et al. 2018. Stem Cells. 36:1421. PubMed
  35. Price AJ, et al. 2018. Nat Commun. 9:5284. PubMed
  36. Sachs N, et al. 2019. EMBO J. 38:. PubMed
  37. Li L, et al. 2018. J Clin Invest. 128:4525. PubMed
  38. Sundberg JP, et al. 2018. PLoS One. 13:e0205775. PubMed
  39. Santoro A, et al. 2019. Cell Rep. 26:624. PubMed
  40. Choo MK, et al. 2018. Sci Signal. 11:551. PubMed
  41. Flores A, et al. 2019. Nat Commun. 10:91. PubMed
  42. Joshi PA, et al. 2019. Nat Commun. 10:1760. PubMed
  43. Ren G, et al. 2019. Sci Rep. 9:6688. PubMed
  44. Gao Y, et al. 2019. Life Sci Alliance. 2:3. PubMed
  45. Devos M, et al. 2017. J Invest Dermatol. 137:494. PubMed
  46. Yamamoto–Fukuda T, et al. 2018. J Assoc Res Otolaryngol. 19:223. PubMed
  47. Sirka OK, et al. 2018. J Cell Biol. 217:3368. PubMed
  48. Smith P, et al. 2019. Sci Rep. 9:7079. PubMed
  49. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  50. Wohlfahrt T, et al. 2019. Nature. 566:344. PubMed
  51. Norum JH, et al. 2019. Int J Cancer. web only. PubMed
  52. Castillo–Azofeifa D, et al. 2018. Development. 145. PubMed
  53. May AJ, et al. 2018. Development. 145. PubMed
  54. Stratikopoulos EE, et al. 2019. Oncogene. 38:47. PubMed
  55. Kim SJ, et al. 2019. Oncogene. 38:5942. PubMed
  56. Schipper K, et al. 2019. Nat Commun. 10:3800. PubMed
  57. Zhao C, et al. 2017. Science. 356:eaal3485. PubMed
  58. Suen AA, et al. 2018. Toxicol Pathol. 46:574. PubMed
  59. Esposito M, et al. 2019. Nat Cell Biol. 21:627. PubMed
  60. Dravis C et al. 2018. Cancer cell. 34(3):466-482 . PubMed
  61. Trisno SL et al. 2018. Cell stem cell. 23(4):501-515 . PubMed
  62. Song Y et al. 2018. Cell reports. 25(11):2981-2991 . PubMed
  63. Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed
  64. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  65. Narla ST et al. 2019. Am J Pathol. 190(1):108-124 . PubMed
  66. Kalan LR et al. 2019. Cell host & microbe. 25(5):641-655 . PubMed
  67. Spurgeon ME et al. 2019. Elife. 8 pii: e50056. PubMed
  68. Hannezo E et al. 2017. Cell. 171(1):242-255 . PubMed
Publication Library
RRID
AB_2565048 (BioLegend Cat. No. 905301)

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 05/11/2017

Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login/Register
Forgot your password? Reset Password
Request an Account